SLC7A11 and SATB2 associated disorder: As shown in Figure 10, GSH levels were drastically reduced from 36.4Mm to 29.4Mm in OCSCs treated with SAS; while in BCSCs a reduction from 39.1Mm in control to 30.6Mm in SAS treated cells was observed suggesting that SAS a SLC7A11 inhibitor induced ferroptosis by lowering reduced GSH levels in both CSCs.